NISSUI PHARMACEUTICAL CO., LTD. Note:This document is a translation of a part of the original Japanese version and provided for reference purposes only. In the event of any discrepancy between the Japanese original and this English translation, the Japanese original shall prevail.
Consolidated Financial Results for the Nine Months Ended December 31, 2020
[Japanese GAAP]
Company name: Nissui Pharmaceutical Co.,Ltd. Stock exchange listing: Tokyo
Code number: 4550
URL:https://www.nissui-pharm.co.jpRepresentative: Tokuya Ono Contact: Shin Saitou Phone: 03-5846-5611
President
Board Member, Executive OfficerScheduled date of filing quarterly securities report: February 10, 2021 Scheduled date of commencing dividend payments: -
Availability of supplementary briefing material on quarterly financial results: No Schedule of quarterly financial results briefing session: No
January 28, 2021
(Amounts of less than one million yen are rounded down)
1. Consolidated Financial Results for the Nine Months Ended December 31, 2020 (April 01, 2020 to December 31, 2020)
(1) Consolidated Operating Results
(% indicates changes from the previous corresponding period.)
Net sales | Operating profit | Ordinary profit | Profit attributable to owners of parent | |||||
Nine months ended December 31, 2020 December 31, 2019 | Million yen 8,602 9,318 | % (7.7) 0.9 | Million yen 537 770 | % (30.3) (18.0) | Million yen 667 804 | % (17.0) (18.8) | Million yen 454 493 | % (7.9) 6.5 |
(Note) Comprehensive income:
Nine months ended December 31, 2020:
Nine months ended December 31, 2019:
¥ ¥
Basic earnings per share | Diluted earnings per share | |
Nine months ended December 31, 2020 December 31, 2019 | Yen 20.32 22.05 | Yen - - |
(2) Consolidated Financial Position
510 million
[ (1.9) %]
520 million
[ 30.1%]
Total assets | Net assets | Capital adequacy ratio | |
As of December 31, 2020 March 31, 2020 | Million yen 35,350 35,203 | Million yen 32,227 32,176 | % 91.2 91.4 |
(Reference) Equity: | As of | December 31, 2020: | ¥ | 32,227 million |
As of | March 31, 2020: | ¥ | 32,176 million | |
1 |
2. Dividends
Annual dividends | |||||
1st quarter-end | 2nd quarter-end | 3rd quarter-end | Year-end | Total | |
Fiscal year ended March 31, 2020 Fiscal year ending March 31, 2021 | Yen - - | Yen 20.00 10.00 | Yen - - | Yen 10.00 | Yen 30.00 |
Fiscal year ending March 31, 2021 (Forecast) | 10.00 | 20.00 |
(Note) Revision to the forecast for dividends announced most recently: No
(Note) Breakdown of the 3rd quarter dividend for the fiscal year ending March 31, 2021 :Commemorative dividend Special dividend
- yen - yen
3. Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2021(April 01, 2020 to March 31, 2021)
(% indicates changes from the previous corresponding period.)
Net sales | Operating profit | Ordinary profit | Profit attributable to owners of parent | Basic earnings per share | |||||
Full year | Million yen 10,400 | % (18.6) | Million yen 630 | % (45.0) | Million yen 730 | % (26.4) | Million yen 490 | % 21.9 | Yen 21.88 |
(Note) Revision to the financial results forecast announced most recently: No
* Notes:
(1) Changes in significant subsidiaries during the nine months ended December 31, 2020
(changes in specified subsidiaries resulting in changes in scope of consolidation): New - (Company name:
Exclusion: - (Company name:
Yes ) )
(2) Accounting policies adopted specially for the preparation of quarterly consolidated financial statements:No
(3) Changes in accounting policies, changes in accounting estimates and retrospective restatement
1) Changes in accounting policies due to the revision of accounting standards: No
2) Changes in accounting policies other than 1) above: No
3) Changes in accounting estimates: No
4) Retrospective restatement: No
(4) Total number of issued shares (common shares)
1) Total number of issued shares at the end of the period (including treasury shares):December 31, 2020:
March 31, 2020:
22,547,140 shares 22,547,140 shares
2) Total number of treasury shares at the end of the period:December 31, 2020:
March 31, 2020:
152,743 shares 152,692 shares
3) Average number of shares during the period:
Nine months ended December 31, 2020: Nine months ended December 31, 2019:
22,394,415 shares 22,394,648 shares
2
Attachments
- Original document
- Permalink
Disclaimer
Nissui Pharmaceutical Co. Ltd. published this content on 28 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 February 2021 11:24:09 UTC.
